Count | |
| 1 | |
| 10 | |
| 4 | |
| 7 | |
| 45 | |
| 21 | |
| 2 | |
| 2 | |
| 8 | |
| 7 | |
| 1 | |
| 3 | |
| 86 | |
| 13 | |
| 1 | |
| 8 | |
| 4 | |
| 25 | |
| 20 | |
| 6 | |
| 2 | |
| 26 | |
| 2 | |
| 3 | |
| 1 | |
| 6 | |
| 1 | |
| 2 | |
| 5 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
alpha 1-Antitrypsin Deficiency/*blood/complications/genetics | 1 |
alpha 1-Antitrypsin Deficiency/*genetics/*immunology/pathology | 1 |
| 1 | |
alpha 1-Antitrypsin/administration & dosage/*genetics/immunology | 1 |
alpha 1-Antitrypsin Deficiency/*complications/genetics/metabolism | 1 |
alpha 1-Antitrypsin/isolation & purification/metabolism/*pharmacokinetics | 1 |
| 1 | |
alpha 1-Antitrypsin/*chemistry/isolation & purification/*pharmacology | 1 |
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 16 |
| 1 | |
| 12 | |
| 5 | |
| 2 | |
| 6 | |
| 5 | |
| 2 | |
| 4 | |
| 1 | |
| 11 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 44 | |
| 10 | |
| 9 | |
| 1 | |
| 3 | |
| 8 | |
| 5 | |
| 2 | |
| 1 | |
| 1 | |
| 15 | |
| 5 | |
| 2 | |